University Of Tasmania

File(s) under permanent embargo

Compatibility and stability of fentanyl admixtures in polypropylene syringes

journal contribution
posted on 2023-05-16, 11:10 authored by Gregory PetersonGregory Peterson, Miller, KAL, Galloway, JG, Dunne, PF
Objective: To determine the physicochemical stability of fentanyl in combination with midazolam and either hyoscine butylbromide or metoclo- pramide, and stored in 30 ml polypropylene syringes. Methods: Solutions containing approximately 40 ìg/ml of fentanyl in combination with midazolam (approximately 600 ìg/ml) and either metoclopramide (approximately 700 ìg/l) or hyoscine (approximately 850 ìg/ml) were prepared from commercial ampoules of the drugs. The solutions were stored, in triplicate, in the dark at 32 °C (to simulate usage conditions) for 10 days, and the concentration of each constituent drug was periodically determined using a stability-indicating high-performance liquid chromatography assay. Results: The combinations were relatively stable, with all drugs maintaining over 90% of their initial chemical potency for at least 1 week. There were no evident changes in either the physical appearance or pH values of the solutions over the course of the study. Conclusions: On the basis of physicochemical stability, polypropylene syringes containing fentanyl with midazolam and either hyoscine butylbromide or metoclopramide can be safely prepared and stored at or below 32 °C for periods of up to 1 week prior to use by palliative care patients receiving the drugs via a portable subcutaneous infusion device.


Publication title

Journal of Clinical Pharmacy and Therapeutics








School of Pharmacy and Pharmacology


Blackwell Science Ltd

Place of publication


Rights statement

The definitive published version is available online at:

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics